Medlive Technology Statistics
Total Valuation
HKG:2192 has a market cap or net worth of HKD 8.94 billion. The enterprise value is 4.61 billion.
Market Cap | 8.94B |
Enterprise Value | 4.61B |
Important Dates
The next estimated earnings date is Tuesday, May 27, 2025.
Earnings Date | May 27, 2025 |
Ex-Dividend Date | May 12, 2025 |
Share Statistics
HKG:2192 has 732.88 million shares outstanding. The number of shares has increased by 0.23% in one year.
Current Share Class | n/a |
Shares Outstanding | 732.88M |
Shares Change (YoY) | +0.23% |
Shares Change (QoQ) | -0.88% |
Owned by Insiders (%) | 1.58% |
Owned by Institutions (%) | 16.55% |
Float | 186.21M |
Valuation Ratios
The trailing PE ratio is 26.79 and the forward PE ratio is 25.78.
PE Ratio | 26.79 |
Forward PE | 25.78 |
PS Ratio | 15.04 |
PB Ratio | 1.73 |
P/TBV Ratio | 1.84 |
P/FCF Ratio | 87.19 |
P/OCF Ratio | 77.57 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 33.13, with an EV/FCF ratio of 44.91.
EV / Earnings | 13.73 |
EV / Sales | 7.75 |
EV / EBITDA | 33.13 |
EV / EBIT | 36.85 |
EV / FCF | 44.91 |
Financial Position
The company has a current ratio of 21.03, with a Debt / Equity ratio of 0.00.
Current Ratio | 21.03 |
Quick Ratio | 20.89 |
Debt / Equity | 0.00 |
Debt / EBITDA | 0.17 |
Debt / FCF | 0.23 |
Interest Coverage | 149.41 |
Financial Efficiency
Return on equity (ROE) is 6.95% and return on invested capital (ROIC) is 1.54%.
Return on Equity (ROE) | 6.95% |
Return on Assets (ROA) | 1.47% |
Return on Invested Capital (ROIC) | 1.54% |
Return on Capital Employed (ROCE) | 2.40% |
Revenue Per Employee | 795,572 |
Profits Per Employee | 448,955 |
Employee Count | 747 |
Asset Turnover | 0.11 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +55.02% in the last 52 weeks. The beta is 0.61, so HKG:2192's price volatility has been lower than the market average.
Beta (5Y) | 0.61 |
52-Week Price Change | +55.02% |
50-Day Moving Average | 13.10 |
200-Day Moving Average | 9.72 |
Relative Strength Index (RSI) | 49.57 |
Average Volume (20 Days) | 4,434,093 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:2192 had revenue of HKD 594.29 million and earned 335.37 million in profits. Earnings per share was 0.46.
Revenue | 594.29M |
Gross Profit | 348.22M |
Operating Income | 124.98M |
Pretax Income | 362.32M |
Net Income | 335.37M |
EBITDA | 128.41M |
EBIT | 124.98M |
Earnings Per Share (EPS) | 0.46 |
Balance Sheet
The company has 4.42 billion in cash and 24.09 million in debt, giving a net cash position of 4.39 billion or 6.00 per share.
Cash & Cash Equivalents | 4.42B |
Total Debt | 24.09M |
Net Cash | 4.39B |
Net Cash Per Share | 6.00 |
Equity (Book Value) | 5.17B |
Book Value Per Share | 6.97 |
Working Capital | 4.42B |
Cash Flow
In the last 12 months, operating cash flow was 115.27 million and capital expenditures -12.73 million, giving a free cash flow of 102.54 million.
Operating Cash Flow | 115.27M |
Capital Expenditures | -12.73M |
Free Cash Flow | 102.54M |
FCF Per Share | 0.14 |
Margins
Gross margin is 58.59%, with operating and profit margins of 21.03% and 56.43%.
Gross Margin | 58.59% |
Operating Margin | 21.03% |
Pretax Margin | 60.97% |
Profit Margin | 56.43% |
EBITDA Margin | 21.61% |
EBIT Margin | 21.03% |
FCF Margin | 17.25% |
Dividends & Yields
This stock pays an annual dividend of 0.27, which amounts to a dividend yield of 2.28%.
Dividend Per Share | 0.27 |
Dividend Yield | 2.28% |
Dividend Growth (YoY) | 40.95% |
Years of Dividend Growth | 3 |
Payout Ratio | 56.81% |
Buyback Yield | -0.23% |
Shareholder Yield | 2.05% |
Earnings Yield | 3.75% |
FCF Yield | 1.15% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
HKG:2192 has an Altman Z-Score of 14.
Altman Z-Score | 14 |
Piotroski F-Score | n/a |